A prospective study of 100 cases of penile cancer managed according to European Association of Urology guidelines
- PMID: 16925747
- DOI: 10.1111/j.1464-410X.2006.06296.x
A prospective study of 100 cases of penile cancer managed according to European Association of Urology guidelines
Abstract
Objective: To prospectively assess the outcome of patients treated according to the European Association of Urology (EAU) guidelines on the management of penile cancer, a system originally based on retrospective series.
Patients and methods: Between 2002 and 2005, 100 consecutive patients (median age 62 years) with penile cancer were treated at one institution; all were categorized and treated according to EAU guidelines. Data were analysed using the z-test, with significance defined as P < 0.05.
Results: Survival curves were limited to those with >12 months of follow-up (mean 29); the survival of the whole group was 92%. Of men with palpable nodes, 72% had lymph node involvement, whereas 18% of those with impalpable nodes who had lymphadenectomy according to the guidelines had lymph node disease. The grade of the primary tumour was more predictive than T stage for lymph node involvement and survival. The 3-year disease-specific survival for N0, N1 and N2 disease was 100%, 100% and 73%, respectively, and survival at 12 months for N3 disease was 67%. The median survival for those with metastases was 3 months.
Conclusion: The overall survival of men with penile cancer is high, with a clear benefit for early lymphadenectomy in men with positive nodal disease. However, the current EAU guidelines are limited in predicting those patients with micrometastatic disease, with the result that 82% of patients undergo unnecessary prophylactic lymphadenectomy. There is a need to identify more accurate molecular markers for predicting lymph node disease, or the role of novel staging techniques must be assessed.
Similar articles
-
Association between lymph node density and disease specific survival in patients with penile cancer.J Urol. 2009 Dec;182(6):2721-7. doi: 10.1016/j.juro.2009.08.029. Epub 2009 Oct 17. J Urol. 2009. PMID: 19837433
-
Long-term followup of penile carcinoma with high risk for lymph node invasion treated with inguinal lymphadenectomy.J Urol. 2010 Jun;183(6):2227-32. doi: 10.1016/j.juro.2010.02.025. J Urol. 2010. PMID: 20399455
-
Lymphatic and vascular embolizations are independent predictive variables of inguinal lymph node involvement in patients with squamous cell carcinoma of the penis: Gruppo Uro-Oncologico del Nord Est (Northeast Uro-Oncological Group) Penile Cancer data base data.Cancer. 2005 Jun 15;103(12):2507-16. doi: 10.1002/cncr.21076. Cancer. 2005. PMID: 15856474
-
[Treatment of lymph nodes in epidermoid carcinoma of the penis: review of literature by the Committee of Cancerology of the French Association of Urology-External Genital Organs Group (CCAFU-OGE)].Prog Urol. 2010 May;20(5):332-42. doi: 10.1016/j.purol.2009.09.015. Epub 2009 Nov 4. Prog Urol. 2010. PMID: 20471577 Review. French.
-
[Diagnosis and therapy for penile cancer: a report of 46 cases with literature review].Ai Zheng. 2008 Sep;27(9):962-5. Ai Zheng. 2008. PMID: 18799036 Review. Chinese.
Cited by
-
Clinical Profile and Predictors of Survival in Carcinoma Penis Patients.Curr Oncol. 2023 Apr 28;30(5):4563-4574. doi: 10.3390/curroncol30050345. Curr Oncol. 2023. PMID: 37232803 Free PMC article.
-
Clinical and Novel Biomarkers in Penile Carcinoma: A Prospective Review.J Pers Med. 2022 Aug 24;12(9):1364. doi: 10.3390/jpm12091364. J Pers Med. 2022. PMID: 36143149 Free PMC article. Review.
-
What Is New in the Diagnosis and Management of Penile Cancer?Indian J Surg Oncol. 2017 Sep;8(3):379-384. doi: 10.1007/s13193-016-0613-2. Epub 2017 Feb 27. Indian J Surg Oncol. 2017. PMID: 36118381 Free PMC article. Review.
-
Lymphovascular and perineural invasion are risk factors for inguinal lymph node metastases in men with T1G2 penile cancer.J Cancer Res Clin Oncol. 2022 Sep;148(9):2231-2234. doi: 10.1007/s00432-022-04012-2. Epub 2022 Apr 12. J Cancer Res Clin Oncol. 2022. PMID: 35411405
-
Modified Inguinal Lymph Node Dissection in Groin-Negative Patients of Penile Cancer: Our Experience.Indian J Surg Oncol. 2021 Mar;12(1):229-234. doi: 10.1007/s13193-021-01285-w. Epub 2021 Feb 5. Indian J Surg Oncol. 2021. PMID: 33814858 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources